Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
| 2021-02-19 Sale |
2021-02-19 3:13 pm |
Cellular Biomedicine Group Inc. | CBMG | Liu Wen Tao Director |
213,076 | $0 | $0 | 0 (Direct) |
View |
| 2021-02-19 Sale |
2021-02-19 3:12 pm |
Cellular Biomedicine Group Inc. | CBMG | Yao Yihong Chief Scientific Officer |
18,900 | $0 | $0 | 88,549 (Direct) |
View |
| 2021-02-19 Sale |
2021-02-19 3:12 pm |
Cellular Biomedicine Group Inc. | CBMG | Chan Andrew K Ch Legal Ofr, Corp Dev & Sec |
239,747 | $0 | $0 | 0 (Direct) |
View |
| 2021-02-19 Sale |
2021-02-19 3:12 pm |
Cellular Biomedicine Group Inc. | CBMG | Liu Tony CEO, CFO |
10,700 | $0 | $0 | 476,817 (Direct) |
View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
| 2021-02-19 Option Award |
2021-02-19 3:12 pm |
N/A N/A |
Cellular Biomedicine Group Inc. | CBMG | Yao Yihong Chief Scientific Officer |
54,000 | $0 | 88,549 (Direct) |
View |
| 2021-02-19 Other |
2021-02-19 3:12 pm |
2016-08-04 2025-08-04 |
Cellular Biomedicine Group Inc. | CBMG | Yao Yihong Chief Scientific Officer |
150,049 | $0 | 88,549 (Direct) |
View |
| 2021-02-19 Option Award |
2021-02-19 3:12 pm |
N/A N/A |
Cellular Biomedicine Group Inc. | CBMG | Chan Andrew K Ch Legal Ofr, Corp Dev & Sec |
48,000 | $0 | 0 (Direct) |
View |
| 2021-02-19 Other |
2021-02-19 3:12 pm |
N/A 2026-04-08 |
Cellular Biomedicine Group Inc. | CBMG | Chan Andrew K Ch Legal Ofr, Corp Dev & Sec |
15,000 | $0 | 0 (Direct) |
View |
| 2021-02-19 Option Award |
2021-02-19 3:12 pm |
N/A N/A |
Cellular Biomedicine Group Inc. | CBMG | Liu Tony CEO, CFO |
240,000 | $0 | 476,817 (Direct) |
View |
| 2021-02-19 Other |
2021-02-19 3:12 pm |
N/A 2023-03-05 |
Cellular Biomedicine Group Inc. | CBMG | Liu Tony CEO, CFO |
1,092,917 | $0 | 476,817 (Direct) |
View |
Ownership |
2020-08-14 4:32 pm |
N/A N/A |
Cellular Biomedicine Group Inc. | CBMG | NOVARTIS PHARMA AG NOVARTIS AG 10% Owner |
0 | $0 | 1,458,257 (Direct) |
View |
| 2020-04-25 Option Award |
2020-04-28 4:24 pm |
2021-04-23 2030-04-25 |
Cellular Biomedicine Group Inc. | CBMG | Au Chun Kwok Alan Director |
6,348 | $0 | 6,348 (Direct) |
View |
| 2020-04-25 Option Award |
2020-04-28 4:24 pm |
2021-04-23 2030-04-25 |
Cellular Biomedicine Group Inc. | CBMG | Belmont Terry Director |
6,348 | $0 | 6,348 (Direct) |
View |
| 2020-04-25 Option Award |
2020-04-28 4:24 pm |
2021-04-23 2030-04-25 |
Cellular Biomedicine Group Inc. | CBMG | Ji Gang Jacky Director |
5,543 | $0 | 5,543 (Direct) |
View |
| 2020-04-25 Option Award |
2020-04-28 4:24 pm |
2021-04-23 2030-04-26 |
Cellular Biomedicine Group Inc. | CBMG | Liu Wen Tao Director |
6,348 | $0 | 6,348 (Direct) |
View |
| 2020-04-25 Option Award |
2020-04-28 4:24 pm |
2021-04-23 2023-04-25 |
Cellular Biomedicine Group Inc. | CBMG | Schafer Edward T Director |
4,983 | $0 | 4,983 (Direct) |
View |
| 2020-04-25 Option Award |
2020-04-28 4:24 pm |
2021-04-23 2030-04-25 |
Cellular Biomedicine Group Inc. | CBMG | Zhou Hansheng Director |
6,976 | $0 | 6,976 (Direct) |
View |